Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-16

FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approved a supplemental application for CHILDRENS ZYRTEC (cetirizine hydrochloride) submitted by Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS ZYRTEC (cetirizine hydrochloride)

Snippet

SUPPL AP for CHILDRENS ZYRTEC (CETIRIZINE HYDROCHLORIDE)